{"entity":{"type":"insider","cik":"0001343678","url":"/insider/0001343678","json_url":"/insider/0001343678.json","name":"Highland Capital Partners VII LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":68,"n_filings":12,"first":"2012-08-02","last":"2021-08-02","span_basis":"filed_date"},"name_variants":[{"name":"Highland Capital Partners VII LP","source":"filing","n_filings":12,"first_seen":"2012-08-02","last_seen":"2021-08-02"}],"transactions":[{"id":4200538,"accession":"0001484778-21-000051","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001484778-21-000051","line_url":"/filing/0001484778-21-000051","is_derivative":false,"issuer_cik":"0001343244","issuer_name":"ThredUp Inc.","issuer_ticker":"TDUP","issuer_name_source":null,"issuer_url":"/issuer/0001343244","owner_cik":null,"owner_name":"Highland Management Partners VII, LLC; Highland Management Partners VII Limited Partnership; Highland Management Partners VIII Ltd; HIGHLAND CAPITAL PARTNERS VII-B L P; Highland Entrepreneurs Fund VII Limited Partnership; Highland Capital Partners VII LP; Highland Capital Partners VII-C LP","owner_display_name":"Highland Management Partners VII, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":372956.0,"shares_display":"372,956","price_per_share":23.1588,"price_display":"23.16","price_state":"stated","total_value":8637213.4128,"total_display":"8,637,213.41","total_whole":"8,637,213","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-02","filed_date":"2021-08-02","scope":"insider","n_lines":4},{"id":4519050,"accession":"0001104659-13-078404","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-13-078404","line_url":"/filing/0001104659-13-078404","is_derivative":false,"issuer_cik":"0001343244","issuer_name":"Gigamon Inc.","issuer_ticker":"GIMO","issuer_name_source":null,"issuer_url":"/issuer/0001343244","owner_cik":null,"owner_name":"Highland Management Partners VII, LLC; HIGHLAND CAPITAL PARTNERS VII-B L P; Highland Capital Partners VII-C LP; Highland Management Partners VII Limited Partnership; Highland Capital Partners VII LP; Highland Entrepreneurs Fund VII Limited Partnership","owner_display_name":"Highland Management Partners VII, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1840347.0,"shares_display":"1,840,347","price_per_share":38.5,"price_display":"38.50","price_state":"stated","total_value":70853359.5,"total_display":"70,853,359.50","total_whole":"70,853,360","shares_owned_after":3550158.0,"shares_owned_after_display":"3,550,158","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-28","filed_date":"2013-10-28","scope":"insider","n_lines":4},{"id":5471330,"accession":"0001104659-13-071668","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001104659-13-071668","line_url":"/filing/0001104659-13-071668","is_derivative":false,"issuer_cik":"0001343244","issuer_name":"HYPERION THERAPEUTICS INC","issuer_ticker":"HPTX","issuer_name_source":null,"issuer_url":"/issuer/0001343244","owner_cik":null,"owner_name":"HIGHLAND CAPITAL PARTNERS VII-B L P; Highland Capital Partners VII-C LP; Highland Entrepreneurs Fund VII Limited Partnership; Highland Management Partners VII, LLC; Highland Capital Partners VII LP; Highland Management Partners VII Limited Partnership","owner_display_name":"HIGHLAND CAPITAL PARTNERS VII-B L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4300.0,"shares_display":"4,300","price_per_share":25.81,"price_display":"25.81","price_state":"stated","total_value":110983.0,"total_display":"110,983.00","total_whole":"110,983","shares_owned_after":1232721.0,"shares_owned_after_display":"1,232,721","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-09-20","filed_date":"2013-09-23","scope":"insider","n_lines":4},{"id":5471317,"accession":"0001104659-13-071668","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-13-071668","line_url":"/filing/0001104659-13-071668","is_derivative":false,"issuer_cik":"0001343244","issuer_name":"HYPERION THERAPEUTICS INC","issuer_ticker":"HPTX","issuer_name_source":null,"issuer_url":"/issuer/0001343244","owner_cik":null,"owner_name":"HIGHLAND CAPITAL PARTNERS VII-B L P; Highland Capital Partners VII-C LP; Highland Entrepreneurs Fund VII Limited Partnership; Highland Management Partners VII, LLC; Highland Capital Partners VII LP; Highland Management Partners VII Limited Partnership","owner_display_name":"HIGHLAND CAPITAL PARTNERS VII-B L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1454.0,"shares_display":"1,454","price_per_share":25.93,"price_display":"25.93","price_state":"stated","total_value":37702.22,"total_display":"37,702.22","total_whole":"37,702","shares_owned_after":1235364.0,"shares_owned_after_display":"1,235,364","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-09-19","filed_date":"2013-09-23","scope":"insider","n_lines":4},{"id":5149251,"accession":"0001104659-13-071134","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001104659-13-071134","line_url":"/filing/0001104659-13-071134","is_derivative":false,"issuer_cik":"0001343244","issuer_name":"HYPERION THERAPEUTICS INC","issuer_ticker":"HPTX","issuer_name_source":null,"issuer_url":"/issuer/0001343244","owner_cik":null,"owner_name":"Highland Capital Partners VII LP; HIGHLAND CAPITAL PARTNERS VII-B L P; Highland Capital Partners VII-C LP; Highland Management Partners VII Limited Partnership; Highland Entrepreneurs Fund VII Limited Partnership; Highland Management Partners VII, LLC","owner_display_name":"Highland Capital Partners VII LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5770.0,"shares_display":"5,770","price_per_share":26.03,"price_display":"26.03","price_state":"stated","total_value":150193.1,"total_display":"150,193.10","total_whole":"150,193","shares_owned_after":1236258.0,"shares_owned_after_display":"1,236,258","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-09-18","filed_date":"2013-09-19","scope":"insider","n_lines":4},{"id":5149239,"accession":"0001104659-13-071134","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-13-071134","line_url":"/filing/0001104659-13-071134","is_derivative":false,"issuer_cik":"0001343244","issuer_name":"HYPERION THERAPEUTICS INC","issuer_ticker":"HPTX","issuer_name_source":null,"issuer_url":"/issuer/0001343244","owner_cik":null,"owner_name":"Highland Capital Partners VII LP; HIGHLAND CAPITAL PARTNERS VII-B L P; Highland Capital Partners VII-C LP; Highland Management Partners VII Limited Partnership; Highland Entrepreneurs Fund VII Limited Partnership; Highland Management Partners VII, LLC","owner_display_name":"Highland Capital Partners VII LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9774.0,"shares_display":"9,774","price_per_share":25.99,"price_display":"25.99","price_state":"stated","total_value":254026.26,"total_display":"254,026.26","total_whole":"254,026","shares_owned_after":1239805.0,"shares_owned_after_display":"1,239,805","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-09-17","filed_date":"2013-09-19","scope":"insider","n_lines":4},{"id":5437418,"accession":"0001104659-13-070475","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001104659-13-070475","line_url":"/filing/0001104659-13-070475","is_derivative":false,"issuer_cik":"0001343244","issuer_name":"HYPERION THERAPEUTICS INC","issuer_ticker":"HPTX","issuer_name_source":null,"issuer_url":"/issuer/0001343244","owner_cik":null,"owner_name":"Highland Entrepreneurs Fund VII Limited Partnership; Highland Management Partners VII Limited Partnership; Highland Capital Partners VII-C LP; Highland Capital Partners VII LP; HIGHLAND CAPITAL PARTNERS VII-B L P; Highland Management Partners VII, LLC","owner_display_name":"Highland Entrepreneurs Fund VII Limited Partnership","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6200.0,"shares_display":"6,200","price_per_share":26.22,"price_display":"26.22","price_state":"stated","total_value":162564.0,"total_display":"162,564.00","total_whole":"162,564","shares_owned_after":1245814.0,"shares_owned_after_display":"1,245,814","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-09-16","filed_date":"2013-09-17","scope":"insider","n_lines":4},{"id":5437411,"accession":"0001104659-13-070475","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-13-070475","line_url":"/filing/0001104659-13-070475","is_derivative":false,"issuer_cik":"0001343244","issuer_name":"HYPERION THERAPEUTICS INC","issuer_ticker":"HPTX","issuer_name_source":null,"issuer_url":"/issuer/0001343244","owner_cik":null,"owner_name":"Highland Entrepreneurs Fund VII Limited Partnership; Highland Management Partners VII Limited Partnership; Highland Capital Partners VII-C LP; Highland Capital Partners VII LP; HIGHLAND CAPITAL PARTNERS VII-B L P; Highland Management Partners VII, LLC","owner_display_name":"Highland Entrepreneurs Fund VII Limited Partnership","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2100.0,"shares_display":"2,100","price_per_share":26.5,"price_display":"26.50","price_state":"stated","total_value":55650.0,"total_display":"55,650.00","total_whole":"55,650","shares_owned_after":1249626.0,"shares_owned_after_display":"1,249,626","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-09-13","filed_date":"2013-09-17","scope":"insider","n_lines":4},{"id":5243063,"accession":"0001104659-13-069607","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001104659-13-069607","line_url":"/filing/0001104659-13-069607","is_derivative":false,"issuer_cik":"0001343244","issuer_name":"HYPERION THERAPEUTICS INC","issuer_ticker":"HPTX","issuer_name_source":null,"issuer_url":"/issuer/0001343244","owner_cik":null,"owner_name":"HIGHLAND CAPITAL PARTNERS VII-B L P; Highland Management Partners VII, LLC; Highland Capital Partners VII LP; Highland Capital Partners VII-C LP; Highland Management Partners VII Limited Partnership; Highland Entrepreneurs Fund VII Limited Partnership","owner_display_name":"HIGHLAND CAPITAL PARTNERS VII-B L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4573.0,"shares_display":"4,573","price_per_share":27.08,"price_display":"27.08","price_state":"stated","total_value":123836.84,"total_display":"123,836.84","total_whole":"123,837","shares_owned_after":1250917.0,"shares_owned_after_display":"1,250,917","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-09-11","filed_date":"2013-09-12","scope":"insider","n_lines":4},{"id":5243044,"accession":"0001104659-13-069607","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-13-069607","line_url":"/filing/0001104659-13-069607","is_derivative":false,"issuer_cik":"0001343244","issuer_name":"HYPERION THERAPEUTICS INC","issuer_ticker":"HPTX","issuer_name_source":null,"issuer_url":"/issuer/0001343244","owner_cik":null,"owner_name":"HIGHLAND CAPITAL PARTNERS VII-B L P; Highland Management Partners VII, LLC; Highland Capital Partners VII LP; Highland Capital Partners VII-C LP; Highland Management Partners VII Limited Partnership; Highland Entrepreneurs Fund VII Limited Partnership","owner_display_name":"HIGHLAND CAPITAL PARTNERS VII-B L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":26.48,"price_display":"26.48","price_state":"stated","total_value":794400.0,"total_display":"794,400.00","total_whole":"794,400","shares_owned_after":1253729.0,"shares_owned_after_display":"1,253,729","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-09-10","filed_date":"2013-09-12","scope":"insider","n_lines":4},{"id":5384259,"accession":"0001104659-13-069051","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001104659-13-069051","line_url":"/filing/0001104659-13-069051","is_derivative":false,"issuer_cik":"0001343244","issuer_name":"HYPERION THERAPEUTICS INC","issuer_ticker":"HPTX","issuer_name_source":null,"issuer_url":"/issuer/0001343244","owner_cik":null,"owner_name":"HIGHLAND CAPITAL PARTNERS VII-B L P; Highland Capital Partners VII-C LP; Highland Entrepreneurs Fund VII Limited Partnership; Highland Management Partners VII, LLC; Highland Capital Partners VII LP; Highland Management Partners VII Limited Partnership","owner_display_name":"HIGHLAND CAPITAL PARTNERS VII-B L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17948.0,"shares_display":"17,948","price_per_share":26.06,"price_display":"26.06","price_state":"stated","total_value":467724.88,"total_display":"467,724.88","total_whole":"467,725","shares_owned_after":1272173.0,"shares_owned_after_display":"1,272,173","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-09-09","filed_date":"2013-09-10","scope":"insider","n_lines":4},{"id":5384241,"accession":"0001104659-13-069051","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-13-069051","line_url":"/filing/0001104659-13-069051","is_derivative":false,"issuer_cik":"0001343244","issuer_name":"HYPERION THERAPEUTICS INC","issuer_ticker":"HPTX","issuer_name_source":null,"issuer_url":"/issuer/0001343244","owner_cik":null,"owner_name":"HIGHLAND CAPITAL PARTNERS VII-B L P; Highland Capital Partners VII-C LP; Highland Entrepreneurs Fund VII Limited Partnership; Highland Management Partners VII, LLC; Highland Capital Partners VII LP; Highland Management Partners VII Limited Partnership","owner_display_name":"HIGHLAND CAPITAL PARTNERS VII-B L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":25.5,"price_display":"25.50","price_state":"stated","total_value":2550.0,"total_display":"2,550.00","total_whole":"2,550","shares_owned_after":1283207.0,"shares_owned_after_display":"1,283,207","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-09-06","filed_date":"2013-09-10","scope":"insider","n_lines":4},{"id":4220604,"accession":"0001104659-13-061036","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-13-061036","line_url":"/filing/0001104659-13-061036#line-4","is_derivative":false,"issuer_cik":"0001343244","issuer_name":"HYPERION THERAPEUTICS INC","issuer_ticker":"HPTX","issuer_name_source":null,"issuer_url":"/issuer/0001343244","owner_cik":null,"owner_name":"HIGHLAND CAPITAL PARTNERS VII-B L P; Highland Entrepreneurs Fund VII Limited Partnership; Highland Management Partners VII Limited Partnership; Highland Management Partners VII, LLC; Highland Capital Partners VII-C LP; Highland Capital Partners VII LP","owner_display_name":"HIGHLAND CAPITAL PARTNERS VII-B L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15369.0,"shares_display":"15,369","price_per_share":25.48,"price_display":"25.48","price_state":"stated","total_value":391602.12,"total_display":"391,602.12","total_whole":"391,602","shares_owned_after":1283268.0,"shares_owned_after_display":"1,283,268","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-08-05","filed_date":"2013-08-07","scope":"insider"},{"id":4220600,"accession":"0001104659-13-061036","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-13-061036","line_url":"/filing/0001104659-13-061036#line-3","is_derivative":false,"issuer_cik":"0001343244","issuer_name":"HYPERION THERAPEUTICS INC","issuer_ticker":"HPTX","issuer_name_source":null,"issuer_url":"/issuer/0001343244","owner_cik":null,"owner_name":"HIGHLAND CAPITAL PARTNERS VII-B L P; Highland Entrepreneurs Fund VII Limited Partnership; Highland Management Partners VII Limited Partnership; Highland Management Partners VII, LLC; Highland Capital Partners VII-C LP; Highland Capital Partners VII LP","owner_display_name":"HIGHLAND CAPITAL PARTNERS VII-B L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5424.0,"shares_display":"5,424","price_per_share":25.48,"price_display":"25.48","price_state":"stated","total_value":138203.52,"total_display":"138,203.52","total_whole":"138,204","shares_owned_after":452852.0,"shares_owned_after_display":"452,852","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-08-05","filed_date":"2013-08-07","scope":"insider"}],"collapsed":true,"next_cursor":"2013-08-05|4220600","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001484778","name":"ThredUp Inc.","url":"/issuer/0001484778","role":"Ten percent owner","n_filings":1,"first_seen":"2021-08-02","last_seen":"2021-08-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001484504","name":"Gigamon Inc.","url":"/issuer/0001484504","role":"Ten percent owner","n_filings":2,"first_seen":"2013-06-17","last_seen":"2013-10-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001386858","name":"HYPERION THERAPEUTICS INC","url":"/issuer/0001386858","role":"Ten percent owner","n_filings":9,"first_seen":"2012-08-02","last_seen":"2013-09-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001343678","retrieved_at":"2026-08-23T11:35:55+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}